Translate
Antengene Corp Ltd
About
Antengene Corp Ltd (HK:6996) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 18 2026
Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs
Mar 20 2026
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
Mar 18 2026
Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs
Mar 3 2026
Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases
Mar 2 2026
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
Recent Videos
Antengene (6996) | Stocks in focus : Meituan, PopMart | 26-3-2026
Mar 26, 2026
Antengene | Employer & Interns' Sharing | HKLSS Life Sciences Summer Internship Program
Dec 19, 2023
Antengene IPO Research - Biotech Play with High-Profile Investors and a Strong Team | Smartkarma
Nov 12, 2020
Financials
Revenue
HK$105.34 M
Market Cap
HK$3.25 B
EPS
-0.36